Anatomic outcomes in patients with subfoveal hemorrhage owing to neovascular age-related macular degeneration treated with intravitreous injections of a vascular endothelial growth factor neutralizing protein. Points show the mean (±95% confidence interval) central subfield thickness (CST) at baseline and 6, 12, 24, 36, 48, and 60 months after baseline. *P < .001 for difference from baseline by unadjusted mixedeffect regression model.